News

/News
News 2018-03-05T19:24:31+00:00

Recros Medica Closes $9M Financing, Strengthens Board

SAN DIEGO, CA, January 4, 2018 – Recros Medica, Inc., a development stage medical aesthetic device company focused on reducing skin laxity and focal contouring, announced today that it has closed a $9M financing. Additionally, the company is strengthening its Board of Directors with the additions of Christoph Westphal, MD, PhD and Mark Kerslake. “We are grateful for the additional read more

Recros Medica Appoints Thomas A. Albright as President and CEO

SAN DIEGO, CA, September 18, 2017 – Recros Medica, Inc., a development stage medical aesthetic device company focused on reducing skin laxity and focal contouring, announced today that Thomas A. Albright has been named President and CEO, and will also serve on the Company’s Board of Directors. Mr. Albright brings nearly 35 years of healthcare experience to Recros Medica, with read more